Tackling Pain and Inflammation: The Bioelectric Solution

“Pain is real, and so is the toll of treating it badly. The promise of bioelectric medicine is not magic — it is a different lever, one we can pull with more precision.”

— Nev Zubcevik, DO, Co-founder & Chief Medical Officer

Start with the human cost, because everything else follows from it. Chronic pain and the inflammation that often drives it are among the largest sources of disability in the world. They empty bank accounts, end careers, and quietly reshape families. They are also one of the central reasons our society reached so readily for opioids — and learned, at terrible scale, what happens when the only tool is a powerful drug.

That is the backdrop for the interest in bioelectric medicine. The nervous system already speaks in electrical pulses; pain itself is, at bottom, an electrical event traveling along nerves. So a natural question is whether we can intervene in that conversation directly, with carefully timed signals, instead of flooding the whole body with chemistry.

From blunt instruments to closed loops

The idea is not new. Transcutaneous electrical nerve stimulation, percutaneous stimulators, and implantable neurostimulators all deliver pulses intended to interrupt or reshape pain signaling. What has changed is the intelligence around the pulse. Older devices delivered the same stimulation regardless of what the body was doing. The newer direction is closed-loop: pair sensors with algorithms so the device reads a patient's state and adapts its output in real time, the way a thermostat responds to a room rather than blasting heat on a fixed schedule.

An illustration of a neuron and its fibers, the cells that carry the body's pain signals. Inflammation adds a second front. One of the more remarkable discoveries in modern physiology is that the nervous system helps regulate the immune system through what researchers call the cholinergic anti-inflammatory pathway. Stimulating the vagus nerve has been studied as a way to engage that built-in brake on inflammation. It is an elegant idea: rather than suppress the immune system broadly, you ask the body's own circuitry to do what it already knows how to do.

“Pain is information. The opportunity in bioelectric medicine is to listen to that signal instead of simply silencing it.”

— Nev Zubcevik, DO, Co-founder & Chief Medical Officer

Why now, and what it is not

I am a CEO, so I will be candid about the case and its limits. The opportunity is large because the unmet need is large, because patients want options that are not addictive, and because the supporting technologies — sensors, low-power electronics, machine learning — have finally matured. The discipline this field needs is equal candor about evidence. We are not promising to replace medicine. We are building toward a multimodal future where bioelectric therapy sits alongside pharmacology, rehabilitation, and lifestyle change, each doing what it does best.

Electrome's role in that future is to make the intelligent layer practical: wearable and implantable stimulators, biosensors, and cloud-based learning models that let therapy improve with use. The measure of success is not a clever device. It is a person who gets their day back.

A clinician examines a patient's back, a common site of chronic pain.